Beth Y. Karlan
- Reproductive Medicine top 0.02%
- Ovarian cancer diagnosis and treatment 169
- Obstetrics and Gynecology top 0.2%
- Endometrial and Cervical Cancer Treatments 34
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 32
- Cancer-related molecular mechanisms research 20
- Oncology top 0.2%
- PARP inhibition in cancer therapy 19
- Genetics top 0.2%
- BRCA gene mutations in cancer 81
-
- Genetic factors in colorectal cancer 24
-
- Reproductive Biology and Fertility 20
- Co-authors
- Ilana CassRae Lynn BaldwinAndrew J. LiSteven A. NarodToshiyasu TaniguchiNicole UrbanElizabeth M. SwisherChristine Walsh
- Partner nations
- United StatesCanadaPoland
In The Last Decade
Beth Y. Karlan
325 papers receiving 18.5k citations
Hit Papers
Peers
Comparison fields: 5 of 169
- Reproductive Medicine 6.6k
- Obstetrics and Gynecology 2.0k
- Cancer Research 3.9k
- Oncology 6.4k
- Genetics 4.4k
Countries citing papers authored by Beth Y. Karlan
This map shows the geographic impact of Beth Y. Karlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Y. Karlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Y. Karlan more than expected).
Fields of papers citing papers by Beth Y. Karlan
This network shows the impact of papers produced by Beth Y. Karlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Y. Karlan. The network helps show where Beth Y. Karlan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Beth Y. Karlan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 15 | |
| 2 | 2024 | 14 | |
| 3 | 2022 | 12 | |
| 4 | 2021 | 41 | |
| 5 | 2021 | 31 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 45 | |
| 8 | 2019 | 66 | |
| 9 | 2018 | 40 | |
| 10 | 2018 | 17 | |
| 11 | 2018 | 19 | |
| 12 | 2012 | 102 | |
| 13 | 2012 | 39 | |
| 14 | 2011 | 378 | |
| 15 | 2011 | 64 | |
| 16 | 2010 | 41 | |
| 17 | 2010 | 135 | |
| 18 | 2009 | 47 | |
| 19 | 2008 | 346 | |
| 20 | 2006 | 118 |
About Beth Y. Karlan
Beth Y. Karlan is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Cancer Research, having authored 336 papers that have together received 18.9k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (169 papers), BRCA gene mutations in cancer (81 papers), Endometrial and Cervical Cancer Treatments (34 papers), Cancer Genomics and Diagnostics (32 papers), Genetic factors in colorectal cancer (24 papers), Reproductive Biology and Fertility (20 papers), Cancer-related molecular mechanisms research (20 papers) and PARP inhibition in cancer therapy (19 papers). The work is most often cited by research in Reproductive Medicine (6.6k citations), Obstetrics and Gynecology (2.0k citations) and Cancer Research (3.9k citations). Beth Y. Karlan has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Ilana Cass, Rae Lynn Baldwin, Andrew J. Li, Steven A. Narod, Toshiyasu Taniguchi, Nicole Urban, Elizabeth M. Swisher, Christine Walsh, Ursula A. Matulonis and Robert E. Bristow. Their work appears in journals such as Nature, New England Journal of Medicine and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.